In a report released today, Steve Beuchaw from Morgan Stanley maintained a Hold rating on Waters Corp (NYSE: WAT), with a price target of $211. The company’s shares closed yesterday at $181.50, close to its 52-week low of $180.21.
According to TipRanks.com, Beuchaw is a 4-star analyst with an average return of 12.6% and a 64.6% success rate. Beuchaw covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA Inc, Myriad Genetics, and NanoString Tech.
The word on The Street in general, suggests a Hold analyst consensus rating for Waters Corp with a $204 average price target, representing a 12.4% upside. In a report released yesterday, UBS also initiated coverage with a Hold rating on the stock with a $210 price target.
Based on Waters Corp’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $156 million. In comparison, last year the company had a net profit of $136 million.
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock. Most recently, in August 2018, Elizabeth Rae, the SVP, Global HR of WAT sold 4,000 shares for a total of $762,480.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Waters Corp. is a specialty measurement company, which engages in the analytical workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis innovations. It operates through Waters and TA segments.